TUSTIN, CA: Radient Pharmaceuticals will launch a national outreach campaign at the beginning of next year to generate sales of its Onko-Sure cancer test.
Onko-Sure is an in vitro diagnostic blood biomarker test used for monitoring colorectal cancer during and after treatment. The initiative will help to differentiate the test from other clinical cancer markers and tests. The effort is targeting physicians, labs, and patients.
There are approximately 5 million individual carcinoembryonic antigen tests performed annually in the US, the company ...